Identification of the *Drosophila* JAK-STAT Pathway
===================================================

The molecular characterization of the JAK-STAT pathway has recently celebrated its 20th birthday, a milestone that marks the discovery of the tyrosine kinases TYK2 and JAK1 and the STAT1 and STAT2 transcription factors as the key factors underlying the cellular response to type I interferons.[@R1] The initial description of the first JAK-STAT pathway components sparked a flurry of activity in multiple labs, which rapidly characterized a wide range of ligands, receptors, four JAKs, and seven STATs present in vertebrate cells. Collectively these factors signal through fundamentally similar mechanisms; a JAK-STAT pathway that now serves as a textbook example of how extracellular ligands can act at the cell surface to modulate nuclear gene expression.[@R2]^-^[@R4]

Hopscotch---the fly JAK
-----------------------

In contrast to the key role played by the *Drosophila* system in identifying many other key cellular signaling cascades, the initial steps leading to the identification of the *Drosophila* JAK-STAT pathway components lagged pioneering work being undertaken in vertebrate cell-based systems. However, the ball was set rolling in 1994 when the Perrimon lab cloned a novel gene termed Hopscotch (Hop), which encodes a maternally supplied protein required for the patterning of the embryonic cuticle (for an example of the LOF phenotype see [Fig. 1](#F1){ref-type="fig"}) and the proliferation of diploid imaginal cells.[@R5]^,^[@R6] Cloning of Hop identified it as a 1177 amino acid non-receptor tyrosine kinase, expressed throughout development, with a kinase domain, sharing 39% identity with JAK1, JAK2, and Tyk2, and an overall identity of 27% to JAK2. While not necessarily apparent at the time, the identification of JAK and the characteristic segmentation phenotype associated with pathway mutants represented a key insight and the first step on the path toward identifying the rest of the pathway.

![**Figure 1.** The embryonic cuticle phenotype associated with wild-type (**A**) and loss of JAK-STAT pathway activity (**B**)---in this case involving the removal of maternally contributed STAT92E. Head skeleton (HS) and posterior spiracles (PS) are both disrupted in pathway mutants. In addition, of the abdominal segments 1 to 8 (a1 to a8) a4 and a5 are missing and a8 reduced in the *stat92E* mutant. Figure reproduced with permission from reference [@R49].](jkst-2-e25353-g1){#F1}

The *Drosophila* STAT
---------------------

Encouraged by the presence of at least one JAK kinase in *Drosophila*, and following a similar biochemical approach to that successfully employed in vertebrate cells, STAT-like activities were also soon demonstrated in vanadate/peroxide stimulated *Drosophila* S2 cells.[@R7] This activity was identified on the basis of its ability to bind to a gamma-interferon response region containing a consensus STAT1 binding sequence. Molecular cloning and characterization of *Drosophila* STAT92E (then termed *marelle* and *D-stat*) was subsequently announced in two back-to-back *Cell* papers in 1996.[@R8]^,^[@R9] Following up on the biochemical approach, the Darnell lab used a low stringency-PCR to clone *Drosophila* STAT, a transcription factor sharing its overall domain structure, and 33% overall amino acid identity, with human STAT5. They showed that STAT92E can be phosphorylated on a tyrosine residue conserved in vertebrate STATs and is able to bind to a consensus palindromic DNA sequence which is present in the promoter of the pair-rule gene *evenskipped* (*eve*)[@R9]---an insight into the segmentation phenotypes characteristic of fly JAK-STAT pathway mutants.[@R10] By contrast, the parallel identification of STAT92E in the Perrimon lab followed the more traditional genetic approach involving a large-scale screen for autosomal lethal mutations associated with specific maternal-effect phenotypes.[@R11] This screen identified P-element insertions in the STAT92E locus. In addition to allowing the rapid cloning of the STAT92E coding region, the insertional mutation also gave a segmentation phenotype ([Fig. 1](#F1){ref-type="fig"}) very similar to that associated with maternal loss of Hop and a stripe-specific disruption in the expression of *runt* and *eve*. Epistatic analysis showed that STAT92E genetically interacts with weak Hop mutants in a manner consistent with STAT92E representing a bona fide downstream component of the pathway.[@R8]

The Outstretched/Unpaired family of ligands
-------------------------------------------

Although originally named on the basis of a regulatory allele that produces an adult outstretched wing phenotype,[@R12] amorphic alleles of the *unpaired* (*upd*) locus were first described in the Nobel Prize-winning saturation screen for loci affecting embryonic segmentation.[@R13] Showing an atypical gap gene phenotype (described below and similar to [Fig. 1A](#F1){ref-type="fig"}), which was later to be associated with loss of Hop and STAT92E, *upd* alleles were subsequently analyzed by generating mosaic mutant embryos. In this elegant example of genetic analysis, Gergen and Wieschaus showed that the protein encoded by the *upd* locus is likely to encode a diffusible factor that acts before gastrulation to influence the action of other genes.[@R14] Based on the embryonic segmentation phenotype, as well as the conclusions of the genetic analysis,[@R15] the Perrimon lab went on to characterize and clone the Upd locus. In addition to interacting genetically with *hop* mutants, Upd protein was found to be a dynamically expressed, secreted and glycosylated protein that interacts with the ECM and is able to activate both Hop and STAT92E in cell based systems.[@R16]^-^[@R18] While much attention was focused on Upd as the "primary" JAK-STAT pathway ligand, publication of the *Drosophila* genome[@R19] showed that two additional homologous genes are located in the genomic region surrounding Upd. Of these, *upd2* is expressed in the same pattern as *upd* and encodes a secreted molecule that does not appear to be ECM associated, and thus has the potential to act systemically in vivo.[@R17] While *upd2* mutants are viable, expression of Upd2 can partially rescue the lethality of the *upd^YM55^* nonsense mutation[@R17] and has recently been shown to play a pivotal role in nutrient sensing and insulin release.[@R20] The third *Drosophila* JAK-STAT ligand, Upd3, is also secreted and able to interact with the ECM;[@R21] however, its expression is more restricted with roles in the response to septic injury[@R22] and the differentiation of lamellocytes in the developing lymph gland[@R23] having been described.

The search for a receptor
-------------------------

Despite the identification of Hop in 1994, STAT92E in 1996, and the first characterization of Upd ligands in 1998, the identity of the pathway receptor remained unclear for some years. Indeed, even the publication of the *Drosophila* genome in 2000 and knowledge of vertebrate receptors such as GP130 and IL6R, searches based on sequence similarities were unable to identify the "missing" receptor. However, once again the embryonic segmentation phenotype, characteristic of JAK-STAT pathway mutants, gave the clue. In the Hombria lab, partial cloning of a protein with Fibronectin type III domains, whose loss affected embryonic posterior spiracles (structures also affected in *hop* and *stat92E* mutants), prompted the generation of germline clones, giving the loss of A5 cuticle phenotype.[@R24] Biochemical characterization of the Domeless (Dome) locus showed that it encoded a transmembrane protein with homology to GP130 that is absolutely required for the expression of JAK-STAT pathway target genes.[@R24] A later, biochemical identification of Dome by the Hou lab, confirmed these findings and demonstrated physical interactions of Dome with STAT92E and its requirement for Upd-induced phosphorylation of pathway components.[@R25] Strikingly, while vertebrate systems contain many receptors, the three JAK-STAT pathway ligands present in flies, all signal through the same receptor.

This, however, turned out not to be the full story following the analysis of a gene lying immediately adjacent to *dome* that had originally been described as encoding a short Dome-like protein lacking an intracellular tail.[@R26] In two recent reports, this locus has been shown to act as a negative regulator of pathway signaling both by RNAi screening and in vivo.[@R23]^,^[@R27] Termed *latran*/*eye transformer*, this co-receptor contains a putative cytokine binding motif and can be co-immunoprecipitated with Dome and Hop, while its knockdown in S2 cells leads to increased STAT92E phosphorylation and transcriptional activity.[@R27] The Crozatier group extended analysis of Latran to the lymph gland where its upregulation is a specific response to infestation by the parasitic wasp *Leptopilina boulardi*. They showed that downregulation of JAK-STAT pathway activity within the lymph gland is not only mediated by increased Latran expression, but also that this decrease is an essential for the differentiation of the lamellocyte blood cell lineage (see the review by Morin-Poulard et al., in this issue). Given the multitude of mechanisms by which the pathway can be downregulated (described below), it is intriguing that a negative co-receptor has evolved to regulate a single differentiation event in one tissue---it will be intriguing to see if Latran ultimately turns out to have, as yet, undiscovered secrets.

Negative pathway regulators
---------------------------

Following the cloning and initial characterization of the core *Drosophila* JAK-STAT pathway components, identification of potential regulators based on homology to the vertebrate pathway followed rapidly. This included the discovery of a *Drosophila* PIAS homolog as a negative modulator of STAT92E and a regulator of chromosomal integrity[@R28]^,^[@R29] and the identification of three *Drosophila* SOCS family members (reviewed in ref. [@R30]). Of these, SOCS36E has been best characterized both as a transcriptional target of the pathway, and as a potent negative regulator of not only JAK-STAT, but also EGFR, pathways.[@R31]^-^[@R34]

Finally, the tyrosine phosphatase, Ptp61F, was one of the last components to be discovered; identified as a potent negative regulator of JAK-STAT pathway signaling by two independent genome-wide RNAi screens,[@R18]^,^[@R35] Ptp61F nonetheless represents the least well characterized regulator. Indeed, the existence of multiple splice forms and differing results has led to both STAT92E and the Hop/Dome receptor complex being proposed as substrates.[@R31]^-^[@R34] Indeed, given that Dome, Hop, and STAT92E are all tyrosine phosphorylated, it is likely that other phosphatases targeting each component are functioning in vivo*.* More research into the dynamics of phosphatase activity, the identity of Ptp61F substrates, the potential role of the *Drosophila* SHP2 homolog, Corkscrew, and the validity of other phosphatases identified by RNAi screens all remain to be determined.

*Drosophila* JAK-STAT Phenotypes
================================

The phenotypes and genetic interactions associated with JAK-STAT signaling form a key aspect of the reviews in this issue. While the cloning of the *Drosophila* JAK, STAT, ligand, and receptor may have lagged progress in vertebrate systems, the developmental genetic analysis available in the *Drosophila* system has made it one of the most powerful systems in which to examine the phenotypes associated with pathway disruption. Indeed, some of the first pathway phenotypes to be defined emerged from studies in the fruit fly.

Outstretched wings and small eyes
---------------------------------

*Drosophila* geneticists, working over 80 years ago, are likely to have been the first scientists to observe and describe a JAK-STAT pathway phenotype. Named on the basis of their viable loss of function phenotypes, flies with *outstretched* wing posture and *small eye* phenotypes were collected and described.[@R12] Only since the development of suitable genetic tools have these been shown to be viable hypomorphic alleles of the *upd* locus. Indeed, only very recently has the *outstretched* wing phenotype of adult wings held almost at 90° to the main body axis been shown to be caused by a defect in the development of the adult wing hinge.[@R36] Characterization of *outstretched* alleles, show the loss of hinge structures in the dorsal adult wing, to result from the loss of one of five *upd* expression domain within the wing imaginal disc. Given the co-localization of the missing *upd* expression domain within a fold that also lies close to the fate mapped position of the missing hinge structure, it seems likely that the basis of this phenotype has now been solved.

While no molecular or gene expression changes associated with the *small eye* phenotype of the original *upd* alleles have been described, a requirement for the JAK-STAT pathway in the proliferation of cells within the developing eye imaginal disc likely provides an explanation for the effect.[@R37] Consistent with this, the original characterization of Hop noted that "all larval diploid imaginal tissues are reduced in size, thus implying a zygotic role for hop in cellular proliferation".[@R6]

Atypical gap-gene phenotypes
----------------------------

Described some years later,[@R13] the embryonic segmentation phenotype associated with the loss of Upd, and indeed all core JAK-STAT pathway components, was a key factor in the identification of several pathway components. The defect is most readily characterized by the deletion of the fifth abdominal denticle belt (a5) and the posterior/mid-ventral portion of the fourth abdominal denticle belt (a4). Loss of pathway activity also leads to defects in the thoracic segments, the head skeleton, a8 and tail regions including the posterior spiracles ([Fig. 1](#F1){ref-type="fig"}). Fusions of the sixth and seventh abdominal segments are also occasionally observed. Although clear in retrospect, the variable expressivity of the phenotype and the nature of the phenotype, which falls outside the broad "maternal, gap, pair-rule, or segment polarity" categorizations, lead to initial confusion and the characterization of *upd* alleles as representing an "atypical gap gene".[@R13] Although the expression of gap genes appears normal in Hop mutants, stripe-specific defects in the expression patterns of the pair-rule genes *even-skipped* (*eve*), *runt*, and *fushi tarazu* (*ftz*) are found.[@R6]^,^[@R10] While not characterized within the promoters controlling every missing stripe, in the case of *eve*, JAK-STAT pathway activity acts as a transcriptional activator via a pair of STAT92E binding sites identified within a 500 bp *eve* stripe 3 promoter region.[@R9] As expected, STAT92E is able to bind to both sites in in vitro mobility shift assays and their mutation in a reporter construct is sufficient to ablate stripe 3 *eve* expression.

While it seems likely that similar STAT92E binding activities control *runt* and *ftz* the precise underpinnings of other defects in the head skeleton and thoracic segments remain less clear. However, insights into the roles of JAK-STAT signaling in the posterior spiracles is certainly making progress with new findings into the cell biology underlying the formation of these structures a subject of a dedicated review in this issue.

Hemocyte overproliferation
--------------------------

While loss-of-function mutations in JAK-STAT pathway components provide valuable information about the developmental processes that require STAT92E, insights gained from gain-of-function mutations have provided intriguing insights into mechanisms relevant to human disease. Initially identified on the basis of a dominant temperature sensitive melanotic tumor phenotype,[@R38]^,^[@R39] cloning of the mutation identified the lesion as an amino acid substitution within Hop which generates a potent gain-of-function effect.[@R40] Phenotypically, this gain-of-function allele, termed Hop^Tumorous\ lethal^ (Hop^Tuml^), results in the over-proliferation of hemocytes within the developing larva and the inappropriate differentiation of these hemocytes toward the lamellocyte lineage---a blood cell type that normally specializes in the encapsulation of parasitic wasp eggs. When present in excess, and in the absence of their normal targets, lamellocytes, in Hop^Tuml^ backgrounds, encapsulate one another and rapidly form large melanized cell masses ([Fig. 2](#F2){ref-type="fig"}). Furthermore, this phenotype is not an oddity of this one allele, but is also recapitulated by a second gain-of-function Hop allele, Hop^T42^. Hop^T42^ contains a substitution in a conserved residue present in the JH2 regulatory domain,[@R41] a substitution that, then when mirrored in JAK2, is also sufficient to activate the vertebrate homolog.[@R42]

![**Figure 2.** Third instar larvae either wild-type for the Hop locus (**A**) or carrying one copy of the gain-of-function Hop^T42^ allele (**B**). Larvae with activated Hop alleles have increased numbers of circulating hemocytes which inappropriately differentiate into lamellocytes which then frequently form black melanized tumors (visible in \[**B**\]). See text for details.](jkst-2-e25353-g2){#F2}

Although multiple human leukemias and myelomas have long been associated with constitutive activation of the JAK-STAT pathway,[@R43] the key significance of the Hop^Tuml^ and Hop^T42^ phenotypes was highlighted by the 2005 discovery of the human JAK2 V617F mutations.[@R44]^-^[@R46] Reported essentially simultaneously by three groups, discovery of human JAK2 V617F substitutions as causative for the majority of myeloproliferative neoplasias has revolutionized the JAK-STAT field. The V617F substitution, also located within the JH2 domain of JAK2, results in constitutive activation of the molecule and the massive uncontrolled over proliferation of blood cells. The parallels between gain-of-function Hop alleles, and Hop^T42^ in particular, with human JAK2 V617F, is indeed striking, and suggests that evolutionary conservation of the JAK-STAT pathway extends not just to the molecules, or even the normal functions such as hematopoiesis, but also to the gain-of-function disease states they can cause. Indeed, while the vertebrate field search for mechanisms to inhibit JAK activity in human disease, *Drosophila* has once again been used to raise the bar providing fundamental insights into non-canonical aspects of JAK-STAT pathway signaling arising from the study of Hop^Tuml^ alleles[@R47]^,^[@R48]---a further subject of a review in this issue.

Summary
=======

While not originally discovered or characterized in *Drosophila*, the rapid identification of a complete intact, low complexity ligand/receptor/JAK-STAT pathway in this genetically tractable and developmentally characterized model system, has provided a foundation for a broad and dynamic field. This special review issue summarizes some of the latest discoveries in the field and highlights how simple animal models remain at the forefront of research into the fundamentals of biology and human disease. We do indeed live in interesting times.
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